COPENHAGEN, Denmark; June 9, 2022 – Genmab A/S (Nasdaq: GMAB) announced today that it has commenced a new arbitration under its license agreement with Janssen Biotech, Inc. (Janssen) for daratumumab.

Let’s say two entities entered into a patent license agreement years ago. Everything has been going wonderfully: The patentee has been receiving royalties, and the licensee has been selling its ...

COPENHAGEN, Denmark; April 21, 2023 – Genmab A/S (Nasdaq: GMAB) announced today an award in the second arbitration arising under its license agreement with Janssen Biotech, Inc. (Janssen) for ...

Copenhagen, Denmark; September 22, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that it has commenced binding arbitration of two matters arising under its license agreement with Janssen Biotech, ...

Nokia receives decision in patent license arbitration with LG Electronics Espoo, Finland - The International Court of Arbitration of the International Chamber of Commerce has issued its award for the ...

WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that its arbitration with ...

On Monday, September 18th, the Finnish communications company Nokia (NYSE:NOK) announced that it received a positive decision in a patent arbitration case decided by the International Chamber of ...

Espoo, Finland - The International Court of Arbitration of the International Chamber of Commerce has issued its award for the binding arbitration between Nokia and LG Electronics. The companies had ...